Cellyan Biotechnology Co. (HKPD) Income Statement: Revenue & Earnings

Cellyan Biotechnology Co. Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Cellyan Biotechnology Co., Ltd income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023
Period Ending	Mar 2025	Mar 2024	Mar 2023
Revenue & Gross Profit
Revenue	20.31	16.69	12.56
Cost of Revenue	17.90	13.13	9.82
Gross Profit	2.42	3.56	2.74
Operating Expenses
Research & Development	0.00	0.00	0.00
Selling, General & Administrative	2.22	1.89	1.76
Operating Expenses	2.28	1.89	1.70
Operating Income	0.13	1.67	1.04
Other Income/Expense
Interest Income	0.00	0.00	0.00
Interest Expense	0.10	-0.08	0.02
Other Income/Expense	-0.10	-0.06	-0.02
Income
Income Before Tax	0.04	1.53	1.02
Income Tax Expense	0.06	0.20	0.02
Net Income	-0.03	1.33	1.00
Net Income - Continuous Operations	-0.03	1.33	1.00
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	1.21	2.53	1.76
EBIT	0.13	1.61	1.04
Depreciation & Amortization	1.07	0.06	0.71
Earnings Per Share
Basic EPS	-	-	-
Diluted EPS	-	-	-
Basic Shares Outstanding	9.02	7.37	11.00
Diluted Shares Outstanding	10.21	7.37	11.00